InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2025-05-02 00:00:00 ET · period of report 2025-05-01 · accession 0001628280-25-021897 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2025-05-02 2025-05-01 INSM Lewis William COB, CEO, Dir S - Sale+OE $72.57 -6,830 238.1K -3% -$495.7K
DI 2025-05-02 2025-05-01 INSM Lewis William COB, CEO, Dir M - OptEx $10.85 +6,830 240.8K +3% +$74.1K
DI 2025-05-02 2025-05-01 INSM Lewis William COB, CEO, Dir M - OptEx $0.00 -6,830 170.8K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-01 S D 4,201 $72.78 233,924 I By the Katie Procter Dynasty Trust — — (F3) This is the weighted average sales price representing 4,201 shares sold at prices ranging from $72.59 to $73.10 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
2 Common Common Stock 2025-05-01 S D 2,629 $72.24 238,125 I By the Katie Procter Dynasty Trust — — (F2) This is the weighted average sales price representing 2,629 shares sold at prices ranging from $71.56 to $72.54 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
3 Common Common Stock 2025-05-01 M A 6,830 $10.85 240,754 I By the Katie Procter Dynasty Trust — —
4 Derivative Stock Option (right to buy) 2025-05-01 M D 6,830 $0.00 170,820 I By the Katie Procter Dynasty Trust $10.85 · — to 2026-05-19 6,830 Common Stock (F4) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.